• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

探索外泌体来源的非编码RNA在胶质瘤中的作用及临床潜力。

Exploring the roles and clinical potential of exosome-derived non-coding RNAs in glioma.

作者信息

Jin Peng, Bai Xue

机构信息

Department of Neurosurgery, Hulunbuir People's Hospital, Hulunbuir, Inner Mongolia Autonomous Region 021000, China.

Department of Intensive Care Unit, Hulunbuir People's Hospital, No. 20, Shengli Street, Hailar District, Hulunbuir, Inner Mongolia Autonomous Region 021000, China.

出版信息

IBRO Neurosci Rep. 2025 Feb 5;18:323-337. doi: 10.1016/j.ibneur.2025.01.015. eCollection 2025 Jun.

DOI:10.1016/j.ibneur.2025.01.015
PMID:40034544
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11872630/
Abstract

Non-coding accounts for 98 %-99 % of the human genome and performs many essential regulatory functions in eukaryotes, involved in cancer development and development. Non-coding RNAs are abundantly enriched in exosomes, which play a biological role as vectors. Some biofunctional non-coding RNAs are specifically designed as exosomes for the treatment of cancers such as glioma. Glioma is one of the most common primary tumors within the skull and has varying degrees of malignancy and histologic subtypes of grades I-IV. Gliomas are characterized by high malignancy and an abundant blood supply due to rapid cell proliferation and vascularization, often with a poor prognosis. Exosomal non-coding RNAs can be involved in the tumorigenesis process of glioma from multiple directions, such as angiogenesis, tumor proliferation, metastatic invasion, immune evasion, apoptosis, and autophagy. Therefore, non-coding RNAs in exosomes are suitable as markers or therapeutic targets for early diagnosis of diseases and for predicting the prognosis of a variety of diseases. Regulating exosome production and the level of exosomal non-coding RNA expression may be a new approach to prevent or eliminate glioma. In this review, we review the origin and characteristics of exosomal non-coding RNAs, and introduce the functional studies of exosomal non-coding RNAs in glioma and their potential clinical applications, in order to broaden new ideas for the treatment of glioma.

摘要

非编码序列占人类基因组的98% - 99%,在真核生物中执行许多重要的调控功能,参与癌症的发生发展。非编码RNA在外泌体中大量富集,外泌体作为载体发挥生物学作用。一些具有生物功能的非编码RNA被专门设计用于治疗胶质瘤等癌症。胶质瘤是颅骨内最常见的原发性肿瘤之一,具有不同程度的恶性程度和I - IV级组织学亚型。胶质瘤的特点是恶性程度高,由于细胞快速增殖和血管生成导致血供丰富,预后往往较差。外泌体非编码RNA可从多个方向参与胶质瘤的肿瘤发生过程,如血管生成、肿瘤增殖、转移侵袭、免疫逃逸、凋亡和自噬。因此,外泌体中的非编码RNA适合作为疾病早期诊断的标志物或治疗靶点,以及预测多种疾病的预后。调节外泌体产生和外泌体非编码RNA表达水平可能是预防或消除胶质瘤的一种新方法。在本综述中,我们回顾了外泌体非编码RNA的起源和特征,并介绍了外泌体非编码RNA在胶质瘤中的功能研究及其潜在的临床应用,以期拓宽胶质瘤治疗的新思路。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d92/11872630/7c4efdcf0407/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d92/11872630/4c236f13d3f2/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d92/11872630/6f04b4d30f02/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d92/11872630/7c4efdcf0407/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d92/11872630/4c236f13d3f2/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d92/11872630/6f04b4d30f02/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d92/11872630/7c4efdcf0407/gr3.jpg

相似文献

1
Exploring the roles and clinical potential of exosome-derived non-coding RNAs in glioma.探索外泌体来源的非编码RNA在胶质瘤中的作用及临床潜力。
IBRO Neurosci Rep. 2025 Feb 5;18:323-337. doi: 10.1016/j.ibneur.2025.01.015. eCollection 2025 Jun.
2
Exosomal noncoding RNAs in Glioma: biological functions and potential clinical applications.外泌体非编码 RNA 在神经胶质瘤中的作用:生物学功能及潜在临床应用
Mol Cancer. 2020 Mar 25;19(1):66. doi: 10.1186/s12943-020-01189-3.
3
Exosomal non-coding RNAs have a significant effect on tumor metastasis.外泌体非编码RNA对肿瘤转移有显著影响。
Mol Ther Nucleic Acids. 2022 May 31;29:16-35. doi: 10.1016/j.omtn.2022.05.034. eCollection 2022 Sep 13.
4
Roles of exosome-derived non-coding RNA in tumor micro-environment and its clinical application.外泌体来源的非编码 RNA 在肿瘤微环境中的作用及其临床应用。
Zhejiang Da Xue Xue Bao Yi Xue Ban. 2023 Aug 25;52(4):429-438. doi: 10.3724/zdxbyxb-2023-0056.
5
Biological functions and clinical applications of exosomal long non-coding RNAs in cancer.外泌体长链非编码 RNA 在癌症中的生物学功能和临床应用。
J Cell Mol Med. 2020 Oct;24(20):11656-11666. doi: 10.1111/jcmm.15873. Epub 2020 Sep 14.
6
Exosomal non-coding RNAs in angiogenesis: Functions, mechanisms and potential clinical applications.血管生成中的外泌体非编码RNA:功能、机制及潜在临床应用
Heliyon. 2023 Jul 24;9(8):e18626. doi: 10.1016/j.heliyon.2023.e18626. eCollection 2023 Aug.
7
Role of exosomes in malignant glioma: microRNAs and proteins in pathogenesis and diagnosis.外泌体在恶性脑胶质瘤中的作用:发病机制和诊断中的 microRNAs 和蛋白质。
Cell Commun Signal. 2020 Aug 3;18(1):120. doi: 10.1186/s12964-020-00623-9.
8
Biological functions and clinical applications of exosomal non-coding RNAs in hepatocellular carcinoma.外泌体非编码 RNA 在肝细胞癌中的生物学功能和临床应用。
Cell Mol Life Sci. 2019 Nov;76(21):4203-4219. doi: 10.1007/s00018-019-03215-0. Epub 2019 Jul 12.
9
Exploring the clinical implications and applications of exosomal miRNAs in gliomas: a comprehensive study.探索外泌体微小RNA在胶质瘤中的临床意义及应用:一项综合研究
Cancer Cell Int. 2024 Sep 27;24(1):323. doi: 10.1186/s12935-024-03507-x.
10
The Potential Roles of Exosomal Non-Coding RNAs in Hepatocellular Carcinoma.外泌体非编码RNA在肝细胞癌中的潜在作用
Front Oncol. 2022 Feb 24;12:790916. doi: 10.3389/fonc.2022.790916. eCollection 2022.

引用本文的文献

1
A Real-Time Cell Image Segmentation Method Based on Multi-Scale Feature Fusion.一种基于多尺度特征融合的实时细胞图像分割方法。
Bioengineering (Basel). 2025 Aug 5;12(8):843. doi: 10.3390/bioengineering12080843.

本文引用的文献

1
Exosomes as nature's nano carriers: Promising drug delivery tools and targeted therapy for glioma.外泌体作为天然纳米载体:有望成为治疗神经胶质瘤的药物递送工具和靶向治疗手段。
Biomed Pharmacother. 2025 Jan;182:117754. doi: 10.1016/j.biopha.2024.117754. Epub 2024 Dec 27.
2
The significance of miR-124 in the diagnosis and prognosis of glioma: A systematic review.miR-124 在胶质瘤诊断和预后中的意义:系统评价。
PLoS One. 2024 Nov 1;19(11):e0312250. doi: 10.1371/journal.pone.0312250. eCollection 2024.
3
Biological functions and molecular mechanisms of exosome-derived circular RNAs and their clinical implications in digestive malignancies: the vintage in the bottle.
外泌体来源环状 RNA 的生物学功能和分子机制及其在消化道恶性肿瘤中的临床意义:瓶中的陈酿。
Ann Med. 2024 Dec;56(1):2420861. doi: 10.1080/07853890.2024.2420861. Epub 2024 Nov 1.
4
Hypoxic glioma-derived exosomal miR-25-3p promotes macrophage M2 polarization by activating the PI3K-AKT-mTOR signaling pathway.低氧胶质瘤衍生的外泌体 miR-25-3p 通过激活 PI3K-AKT-mTOR 信号通路促进巨噬细胞 M2 极化。
J Nanobiotechnology. 2024 Oct 16;22(1):628. doi: 10.1186/s12951-024-02888-5.
5
Exosome-mediated delivery of siRNA molecules in cancer therapy: triumphs and challenges.外泌体介导的siRNA分子在癌症治疗中的应用:成就与挑战
Front Mol Biosci. 2024 Sep 17;11:1447953. doi: 10.3389/fmolb.2024.1447953. eCollection 2024.
6
Exploring the clinical implications and applications of exosomal miRNAs in gliomas: a comprehensive study.探索外泌体微小RNA在胶质瘤中的临床意义及应用:一项综合研究
Cancer Cell Int. 2024 Sep 27;24(1):323. doi: 10.1186/s12935-024-03507-x.
7
Dual role of exosomal circCMTM3 derived from GSCs in impeding degradation and promoting phosphorylation of STAT5A to facilitate vasculogenic mimicry formation in glioblastoma.外泌体 circCMTM3 来源于 GSCs 在阻止降解和促进 STAT5A 磷酸化方面的双重作用,促进胶质母细胞瘤血管生成拟态的形成。
Theranostics. 2024 Sep 3;14(14):5698-5724. doi: 10.7150/thno.97057. eCollection 2024.
8
The potential of exosomes as a new therapeutic strategy for glioblastoma.外泌体作为胶质母细胞瘤新治疗策略的潜力。
Eur J Pharm Biopharm. 2024 Oct;203:114460. doi: 10.1016/j.ejpb.2024.114460. Epub 2024 Aug 31.
9
Role of Extracellular Vesicles in the Progression of Brain Tumors.细胞外囊泡在脑肿瘤进展中的作用
Biology (Basel). 2024 Aug 2;13(8):586. doi: 10.3390/biology13080586.
10
Unveiling the multifaceted roles of microRNAs in extracellular vesicles derived from mesenchymal stem cells: implications in tumor progression and therapeutic interventions.揭示间充质干细胞衍生的细胞外囊泡中微小RNA的多方面作用:对肿瘤进展和治疗干预的影响
Front Pharmacol. 2024 Aug 5;15:1438177. doi: 10.3389/fphar.2024.1438177. eCollection 2024.